ELY TAMANO: Open Payments
NPI 1477674265 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 10 payments from 5 companies in 2025. Trend: 2023 $486 · 2024 $234 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Lundbeck LLC | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: Qelbree, REXULTI, ABILIFY ASIMTUFII, CAPLYTA, AUSTEDO XR.
Industry payments across KS — which companies pay providers there.
